Not known Facts About KDM5A-IN-1
quinupristin/dalfopristin will raise the stage or outcome of lemborexant by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Stay away from or Use Alternate Drug. Stay clear of coadministration of lemborexant with average or powerful CYP3A inhibitors.
Slight (1)quinupristin/dalfopristin w